Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfang Liu

Showing results (641-650 of 648) with videos related to

Pageof 65
Sort By:
You have reached the last page of results.This site can display upto 648 results.
Epidemiology (Cambridge, Mass.)|July 2, 2015
Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network ApproachEdward Chia-Cheng Lai, Kenneth K C Man, Nathorn Chaiyakunapruk, et al.
Nature Genetics|June 12, 2019
Mutation of a histidine-rich calcium-binding-protein gene in wheat confers resistance to Fusarium head blightGuoqiang Li, Jiyang Zhou, Haiyan Jia, et al.
Neuro-Oncology|April 14, 2022
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trialAntonio Omuro, Alba A Brandes, Antoine F Carpentier, et al.
Cell|June 25, 2025
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosisXiaobing Wang, Yi Zhang, Yi Jin, et al.
Cell|July 16, 2024
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosisXiaobing Wang, Xin Wu, Binghe Tan, et al.
Nature Medicine|August 27, 2025
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialXiaobing Wang, Yi Zhang, Huimin Wang, et al.
The New England Journal of Medicine|December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Future Oncology (London, England)|September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Pageof 65

Showing results (641-650 of 648) with videos related to

Sort By:
Pageof 65
You have reached the last page of results.This site can display upto 648 results.
Epidemiology (Cambridge, Mass.)|July 2, 2015
Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network ApproachEdward Chia-Cheng Lai, Kenneth K C Man, Nathorn Chaiyakunapruk, et al.
Nature Genetics|June 12, 2019
Mutation of a histidine-rich calcium-binding-protein gene in wheat confers resistance to Fusarium head blightGuoqiang Li, Jiyang Zhou, Haiyan Jia, et al.
Neuro-Oncology|April 14, 2022
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trialAntonio Omuro, Alba A Brandes, Antoine F Carpentier, et al.
Cell|June 25, 2025
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosisXiaobing Wang, Yi Zhang, Yi Jin, et al.
Cell|July 16, 2024
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosisXiaobing Wang, Xin Wu, Binghe Tan, et al.
Nature Medicine|August 27, 2025
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialXiaobing Wang, Yi Zhang, Huimin Wang, et al.
The New England Journal of Medicine|December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Future Oncology (London, England)|September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Pageof 65